Patient Access Insights Coronavirus – Challenges for Pharma & MedTech Companies in the UK, Germany & EU

In this webinar, Christian Hill CEO of MAP BioPharma was joined by Dr. Alexander Natz, Secretary General of EUCOPE and they discussed the challenges the industry is facing and identified potential solutions.
Request this webinar

Coronavirus – Challenges for Pharma & MedTech Companies in the UK, Germany & EU

Request this webinar

Originally broadcast: Thursday, 30th April 2020

Duration: 60 minutes. Available to watch on demand

Learning objectives:

  •  Understand the challenges that Covid-19 presents including:

  •  Legal changes due to COVID-19 in UK, Germany, EU

  •  EMA guidance on clinical trials during crisis

  •  Shortages of Medicines (EMA policy)

  •  Postponement of Medical Device Legislation for one year until 26 May 2021

  •  New challenges regarding counterfeit medicines

  •  EMA priorities

  •  National measures regarding COVID-19

  •  National implications on HTA procedures, scientific advice, price negotiations etc.

  •  Consider these challenges and the consequence on your Market Access approach

  •  Consider potential solutions and how to implement them

  •  Potential virtual partnering event organised by MAP BioPharma

  • The Pharma and MedTech job functions that will benefit most include:

  •  Heads of Market Access

  •  Country Managers

  •  Health Economists

  •  Commercial Directors

  •  Marketing Directors

  •  Managing Directors

  •  Chief Executives

  •  Medical Directors

  •  Policy Officers and Executives

  •  Policy Advisors

Dr. Alexander Natz 
Secretary General
Christian Hill

Chief Executive Officer

Angelika Gornikowska

Legal Counsel

Tessa Hughes

Head of Policy and Public Affairs

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52